COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
coronavirus

CORONAVIRUS

AstraZeneca's same vaccine is manufactured and marketed in India as Covishield.
Updated : May 2, 2024

'Covaxin was developed with safety focus’: Bharat Biotech on Covishield blood clot row

AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)